Detalles de la búsqueda
1.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Br J Haematol
; 204(3): 892-897, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013238
2.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Cytotherapy
; 26(1): 73-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952139
3.
Therapeutic efficacy and safety of pathogen-reduced platelet components: Results of a meta-analysis of randomized controlled trials.
Vox Sang
; 119(3): 203-211, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181391
4.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther
; 30(2): 213.e1-213.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042256
5.
Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study.
Transfus Med Rev
; 38(2): 150824, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38569349
6.
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521885
7.
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Hematol Transfus Cell Ther
; 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37891074
8.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 29(3): 181.e1-181.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526259
9.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Blood Adv
; 7(10): 2018-2031, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453637
10.
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
Cancers (Basel)
; 14(17)2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077644
11.
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
Transplant Cell Ther
; 28(8): 489.e1-489.e9, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577323
12.
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 28(12): 850.e1-850.e10, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089250
13.
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
Transplant Cell Ther
; 27(6): 501.e1-501.e6, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891882
14.
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Bone Marrow Transplant
; 55(7): 1264-1271, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103146
15.
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521886
Resultados
1 -
15
de 15
1
Próxima >
>>